Airway management in a new and changing world

Unfortunately all AIME airway programming is cancelled until fall for obvious reasons. We will do our best to share the work we are doing locally to support airway management providers. Thank you for doing what you do.
​In addition to Open Access Materials below a literature update is in progress.



Severe COVID-19

Download Article


Berlin D et al. NEJM 2020

Evaluation and Management of Severe Covid-19
• Patients with severe coronavirus disease 2019 (Covid-19) may become critically ill with acute respiratory distress syndrome that typically begins approximately 1 week after the onset of symptoms.
• Deciding when a patient with severe Covid-19 should receive endotracheal intubation is an essential component of care.
• After intubation, patients should receive lung-protective ventilation with plateau pressure less than or equal to 30 cm of water and with tidal volumes based on the patient’s height.
• Prone positioning is a potential treatment strategy for refractory hypoxemia. • Thrombosis and renal failure are well-recognized complications of severe Covid-19. • Data are needed from randomized trials to inform the benefits and risks of antiviral or
immunomodulatory therapies for severe Covid-19; as of mid-May 2020, no agents had been approved by the Food and Drug Administration for treatment of these patients.
• Preliminary data from a randomized, placebo-controlled trial involving patients with severe Covid-19 suggest that the investigational antiviral remdesivir shortens time to recovery.

View All

View Articles

Airway Management in Emergencies
(the Infinity Edition)
- a Free Open Access Medical Education resource